VivaQuant®, Inc. d.b.a. Rhythm Express® has been named to the 2026 Inc. 5000, the most prestigious ranking of America’s fastest growing private companies. The recognition highlights the company's continued innovation in remote cardiac monitoring and digital health.

“We are honored to be recognized by Inc. Magazine for the fourth year in a row. This recognition reflects the dedication of our team and our commitment to delivering innovative solutions to improve patient care,” said Brian Brockway, CEO of VivaQuant. “As we expand our portfolio with our recently FDA 510(k)-cleared RX-1 Sleep™ solution, we believe we are uniquely positioned to transform how physicians diagnose both arrhythmias and sleep apnea.”

Marina Brockway, founder and CTO, added: “RX-1 Sleep wirelessly combines our compact RX-1 mini wearable with a small wrist-worn pulse oximeter to concurrently assess severity of sleep related breathing disorders and cardiac arrhythmias in one simple test, providing streamlined and simplified workflows for both patients and clinics. This differentiated approach gives providers actionable clinical insights while reducing obstacles and delays for patients.”

As demand grows for convenient, clinically reliable home-based diagnostics, Rhythm Express is broadening its portfolio with RX-1 Sleep to address one of healthcare's most underdiagnosed conditions, while continuing to advance innovative solutions and improve patient care.

About VivaQuant, Inc.

VivaQuant, Inc. is a digital health company specializing in remote cardiac monitoring and diagnostic services. Through its Rhythm Express^® platform and expanding portfolio of wearable technologies, including RX-1 Sleep and RX-1 mini. To date, the company has helped physician to diagnose heart rhythm in more than 650,000 patients.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260807284937/en/

"RX-1 Sleep wirelessly combines our compact RX-1 mini wearable with a small wrist-worn pulse oximeter to concurrently assess severity of sleep related breathing disorders and cardiac arrhythmias in one simple test" - Marina Brockway, Founder and CTO